Other Species / Isoforms
  AMPKA2 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K41
EHQLTGHKVAVKILN
0 1
AMPKA2 (human) EHQLTGHkVAVKILN K41-ub
AMPKA2 (mouse) EHQLTGHKVAVKILN K41
AMPKA2 (rat) EHQLTGHKVAVKILN K41
AMPKA2 (pig) EHQLTGHKVAVKILN K41
K60
RSLDVVGKIKREIQN
1 1
AMPKA2 (human) RSLDVVGkIKREIQN K60-ub
AMPKA2 (mouse) RSLDVVGkIKREIQN K60-ub
AMPKA2 (rat) RSLDVVGKIKREIQN K60
AMPKA2 (pig) RSLDVVGKIKREIQN K60
K69-ac
KREIQNLkLFRHPHI
0 4
AMPKA2 (human) KREIQNLkLFRHPHI K69-ac
AMPKA2 (mouse) KREIQNLkLFRHPHI K69-ac
AMPKA2 (rat) KREIQNLkLFRHPHI K69-ac
AMPKA2 (pig) KREIQNLKLFRHPHI K69
S165
FGLSNMMSDGEFLRt
0 5
AMPKA2 (human) FGLSNMMsDGEFLRt S165-p
AMPKA2 (mouse) FGLSNMMsDGEFLRt S165-p
AMPKA2 (rat) FGLSNMMSDGEFLRt S165
AMPKA2 (pig) FGLSNMMSDGEFLRt S165
T172-p
SDGEFLRtsCGSPNY
Upstream
Downstream
222 45
AMPKA2 (human)
T172-p
AMPKA2 (mouse)
T172-p
AMPKA2 (rat)
T172-p
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • cell growth, inhibited
Kinase, in vitro:
  • LKB1 (mouse)
Regulatory protein:
  • Akt1 (rat)
  • AS160 (human)
  • LKB1 (human)
view more >
Treatment
  • A-769662
  • acadesine
  • calorie_restriction
  • CB13
  • Cinacalcet
  • clozapine
  • compound_C
  • electrical_stimulation
  • exercise
  • exercise training
  • Far-infrared
  • fasting
  • fructose-rich diet
  • ghrelin
  • heating
  • hypoxia
  • insulin
  • ischemia
  • olanzapine
  • palmitate
  • racepinefrine
  • tachypacing
  • testosterone
view more >
AMPKA2 (human) sDGEFLRtsCGsPNy T172-p
AMPKA2 (mouse) sDGEFLRtsCGsPNY T172-p
AMPKA2 (rat) SDGEFLRtsCGSPNY T172-p
AMPKA2 (pig) SDGEFLRtSCGSPNY T172-p
S173-p
DGEFLRtsCGSPNYA
2 19
AMPKA2 (human) DGEFLRtsCGsPNyA S173-p
AMPKA2 (mouse) DGEFLRtsCGsPNYA S173-p
AMPKA2 (rat) DGEFLRtsCGSPNYA S173-p
AMPKA2 (pig) DGEFLRtSCGSPNYA S173
S176
FLRtsCGSPNYAAPE
0 18
AMPKA2 (human) FLRtsCGsPNyAAPE S176-p
AMPKA2 (mouse) FLRtsCGsPNYAAPE S176-p
AMPKA2 (rat) FLRtsCGSPNYAAPE S176
AMPKA2 (pig) FLRtSCGSPNYAAPE S176
Y179
tsCGSPNYAAPEVIS
1 3
AMPKA2 (human) tsCGsPNyAAPEVIS Y179-p
AMPKA2 (mouse) tsCGsPNYAAPEVIS Y179
AMPKA2 (rat) tsCGSPNYAAPEVIS Y179
AMPKA2 (pig) tSCGSPNYAAPEVIS Y179
R227
PTLFKKIRGGVFYIP
0 1
AMPKA2 (human) PTLFKKIrGGVFyIP R227-m1
AMPKA2 (mouse) PTLFKKIRGGVFYIP R227
AMPKA2 (rat) PTLFKKIRGGVFYIP R227
AMPKA2 (pig) PTLFKKIRGGVFYIP R227
Y232
KIRGGVFYIPEYLNR
0 1
AMPKA2 (human) KIrGGVFyIPEYLNR Y232-p
AMPKA2 (mouse) KIRGGVFYIPDYLNR Y232
AMPKA2 (rat) KIRGGVFYIPEYLNR Y232
AMPKA2 (pig) KIRGGVFYIPEYLNR Y232
T258-p
VDPLKRAtIKDIREH
Upstream
1 1
Kinase, in vitro:
  • LKB1 (mouse)
AMPKA2 (human) VDPLKRATIKDIREH T258
AMPKA2 (mouse) VDPLKRATIKDIREH T258
AMPKA2 (rat) VDPLKRAtIKDIREH T258-p
AMPKA2 (pig) VDPLKRATIKDIREH T258
K269
IREHEWFKQDLPSYL
0 1
AMPKA2 (human) IREHEWFkQDLPSYL K269-ub
AMPKA2 (mouse) IREHEWFKQDLPSYL K269
AMPKA2 (rat) IREHEWFKQDLPSYL K269
AMPKA2 (pig) IREHEWFKQDLPSYL K269
S310
TESEVMNSLYSGDPQ
0 1
AMPKA2 (human) TESEVMNSLYSGDPQ S310
AMPKA2 (mouse) TESEVMNsLYSGDPQ S310-p
AMPKA2 (rat) TESEVMNSLYSGDPQ S310
AMPKA2 (pig) TESEVMNSLYSGDPQ S310
Y324
QDQLAVAYHLIIDNR
0 1
AMPKA2 (human) QDQLAVAyHLIIDNR Y324-p
AMPKA2 (mouse) QDQLAVAYHLIIDNR Y324
AMPKA2 (rat) QDQLAVAYHLIIDNR Y324
AMPKA2 (pig) QDQLAVAYHLVIDNR Y324
S377-p
MPPLIADsPKARCPL
0 28
AMPKA2 (human) MPPLIADsPkARCPL S377-p
AMPKA2 (mouse) MPPLIADsPkARCPL S377-p
AMPKA2 (rat) MPPLIADsPKARCPL S377-p
AMPKA2 (pig) MPPLIADSPKARCPL S377
K379
PLIADsPKARCPLDA
1 1
AMPKA2 (human) PLIADsPkARCPLDA K379-ub
AMPKA2 (mouse) PLIADsPkARCPLDA K379-ub
AMPKA2 (rat) PLIADsPKARCPLDA K379
AMPKA2 (pig) PLIADSPKARCPLDA K379
K391
LDALNTTKPKSLAVK
1 1
AMPKA2 (human) LDALNTTkPKSLAVK K391-ub
AMPKA2 (mouse) LDALNTTKPKSLAVK K391
AMPKA2 (rat) LDALNTTKPKSLAVK K391
AMPKA2 (pig) LDALNTTKPKSLAVK K391
Y436
EWKVVNAYHLRVRRK
1 0
AMPKA2 (human) EWKVVNAyHLRVRRK Y436-p
AMPKA2 (mouse) EWKVVNAYHLRVRRK Y436
AMPKA2 (rat) EWKVVNAYHLRVRRK Y436
AMPKA2 (pig) EWKVVNAYHLRVRRK Y436
K470
RSYLLDFKSIDDEVV
1 2
AMPKA2 (human) RSYLLDFkSIDDEVV K470-ub
AMPKA2 (mouse) RSYLLDFkSIDDEVV K470-ub
AMPKA2 (rat) RSYLLDFKSIDDEVV K470
AMPKA2 (pig) RSYLLDFKSIDDEVL K470
S481
DEVVEQRSGSStPQR
0 6
AMPKA2 (human) DEVVEQRsGsstPQR S481-p
AMPKA2 (mouse) DEVVEQRsGSstPQR S481-p
AMPKA2 (rat) DEVVEQRSGSStPQR S481
AMPKA2 (pig) DEVLEQRSGSSTPQR S481
S483
VVEQRSGSStPQRSC
0 1
AMPKA2 (human) VVEQRsGsstPQRsC S483-p
AMPKA2 (mouse) VVEQRsGSstPQRSC S483
AMPKA2 (rat) VVEQRSGSStPQRSC S483
AMPKA2 (pig) VLEQRSGSSTPQRSC S483
S484
VEQRSGSStPQRSCs
2 2
AMPKA2 (human) VEQRsGsstPQRsCs S484-p
AMPKA2 (mouse) VEQRsGSstPQRSCs S484-p
AMPKA2 (rat) VEQRSGSStPQRSCs S484
AMPKA2 (pig) LEQRSGSSTPQRSCS S484
T485-p
EQRSGSStPQRSCsA
Upstream
2 2
Treatment
  • electrical_stimulation
  • IGF-1
AMPKA2 (human) EQRsGsstPQRsCsA T485-p
AMPKA2 (mouse) EQRsGSstPQRSCsA T485-p
AMPKA2 (rat) EQRSGSStPQRSCsA T485-p
AMPKA2 (pig) EQRSGSSTPQRSCSA T485
S489
GSStPQRSCsAAGLH
0 1
AMPKA2 (human) GsstPQRsCsAAGLH S489-p
AMPKA2 (mouse) GSstPQRSCsAAGLH S489
AMPKA2 (rat) GSStPQRSCsAAGLH S489
AMPKA2 (pig) GSSTPQRSCSAAGLH S489
S491-p
StPQRSCsAAGLHRP
Upstream
Downstream
14 13
AMPKA2 (human)
S491-p
AMPKA2 (rat)
S491-p
Effects on Modified Protein
  • enzymatic activity, inhibited
Kinase, in vitro:
  • LKB1 (mouse)
Putative in vivo kinases:
  • Akt1 (rat)
Regulatory protein:
  • Akt1 (rat)
  • LKB1 (human)
Treatment
  • electrical_stimulation
  • hypoxia
  • IGF-1
  • insulin
  • ischemia
  • phenobarbital
view more >
AMPKA2 (human) stPQRsCsAAGLHRP S491-p
AMPKA2 (mouse) stPQRSCsAAGLHRA S491-p
AMPKA2 (rat) StPQRSCsAAGLHRP S491-p
AMPKA2 (pig) STPQRSCSAAGLHRP S491
S500
AGLHRPRSSVDSSTA
0 3
AMPKA2 (human) AGLHRPRssFDSTTA S500-p
AMPKA2 (mouse) AGLHRARssFDSSTA S500-p
AMPKA2 (rat) AGLHRPRSSVDSSTA S500
AMPKA2 (pig) AGLHRPRSSLDSVTA S500
S501
GLHRPRSSVDSSTAE
0 2
AMPKA2 (human) GLHRPRssFDSTTAE S501-p
AMPKA2 (mouse) GLHRARssFDSSTAE S501-p
AMPKA2 (rat) GLHRPRSSVDSSTAE S501
AMPKA2 (pig) GLHRPRSSLDSVTAE S501
N509
VDSSTAENHSLSGSL
0 1
AMPKA2 (human) FDSTTAEsHsLSGsL S509-p
AMPKA2 (mouse) FDSSTAENHSLSGSL N509
AMPKA2 (rat) VDSSTAENHSLSGSL N509
AMPKA2 (pig) LDSVTAESHSLSGSL S509
S511
SSTAENHSLSGSLTG
0 1
AMPKA2 (human) STTAEsHsLSGsLTG S511-p
AMPKA2 (mouse) SSTAENHSLSGSLTG S511
AMPKA2 (rat) SSTAENHSLSGSLTG S511
AMPKA2 (pig) SVTAESHSLSGSLSG S511
S515
ENHSLSGSLTGSLTG
0 2
AMPKA2 (human) EsHsLSGsLTGSLtG S515-p
AMPKA2 (mouse) ENHSLSGSLTGSLTG S515
AMPKA2 (rat) ENHSLSGSLTGSLTG S515
AMPKA2 (pig) ESHSLSGSLSGSLTG S515
T521
GSLTGSLTGSTLSSA
0 1
AMPKA2 (human) GsLTGSLtGStLSsV T521-p
AMPKA2 (mouse) GSLTGSLTGSTLSSA T521
AMPKA2 (rat) GSLTGSLTGSTLSSA T521
AMPKA2 (pig) GSLSGSLTGSMLPSV T521
T524
TGSLTGSTLSSASPR
0 1
AMPKA2 (human) TGSLtGStLSsVSPR T524-p
AMPKA2 (mouse) TGSLTGSTLSSASPR T524
AMPKA2 (rat) TGSLTGSTLSSASPR T524
AMPKA2 (pig) SGSLTGSMLPSVPPR M524
S527
LTGSTLSSASPRLGS
0 1
AMPKA2 (human) LtGStLSsVSPRLGs S527-p
AMPKA2 (mouse) LTGSTLSSASPRLGS S527
AMPKA2 (rat) LTGSTLSSASPRLGS S527
AMPKA2 (pig) LTGSMLPSVPPRLGS S527
S534
SASPRLGSHTMDFFE
0 1
AMPKA2 (human) sVSPRLGsHTMDFFE S534-p
AMPKA2 (mouse) SASPRLGSHTMDFFE S534
AMPKA2 (rat) SASPRLGSHTMDFFE S534
AMPKA2 (pig) SVPPRLGSHTMDFFE S534